39824 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 16
00:12 UTC
|
AGF.B
AGF Management
|
◎ Target | firm only | Buy | C$24.00→ C$23.00-4.2% |
|
Sep 16
00:12 UTC
|
ABOS
Acumen Pharmaceuticals
|
◎ Target | Geoff Meacham ★★★☆☆ #1350 | Buy | $4.00→ $5.00+25.0% |
|
Sep 15
21:11 UTC
|
INTC
Intel
|
◎ Target | Ivan Feinseth ★★☆☆☆ #2651 | Buy | $118.00→ $145.00+22.9% |
|
Sep 15
19:20 UTC
|
MTY
MTY Food Group
|
◎ Target | firm only | Outperform | C$43.00→ C$40.00-7.0% |
|
Sep 15
19:20 UTC
|
ET
Evertz Technologies
|
◎ Target | firm only | Sec→ r Perform | C$17.00→ C$16.00-5.9% |
|
Sep 15
19:20 UTC
|
ET
Evertz Technologies
|
◎ Target | firm only | Outperform | C$18.00→ C$16.50-8.3% |
|
Sep 15
19:20 UTC
|
ET
Evertz Technologies
|
◎ Target | firm only | Outperform | C$18.00→ C$17.00-5.6% |
|
Sep 15
19:20 UTC
|
ENB
Enbridge
|
◎ Target | firm only | Outperform | C$83.00→ C$84.00+1.2% |
|
Sep 15
19:20 UTC
|
ENB
Enbridge
|
◎ Target | firm only | Market Perform | C$79.00→ C$80.00+1.3% |
|
Sep 15
19:20 UTC
|
CGX
Cineplex
|
◎ Target | firm only | Outperform | C$14.00→ C$15.00+7.1% |
|
Sep 15
19:20 UTC
|
BCE
BCE
|
◎ Target | firm only | Buy | C$37.00→ C$40.00+8.1% |
|
Sep 15
19:20 UTC
|
AGF.B
AGF Management
|
◎ Target | firm only | Buy | C$24.00→ C$23.00-4.2% |
|
Sep 15
18:19 UTC
|
ELF
e.l.f. Beauty
|
◎ Target | Anna Lizzul ★★★★☆ #942 | Buy | $100.00→ $118.00+18.0% |
|
Sep 15
18:19 UTC
|
CSHR
CoinShares
|
◎ Target | Alex Bond ★★★☆☆ #1921 | Outperform | $7.00→ $9.00+28.6% |
|
Sep 15
18:19 UTC
|
CCL
Carnival
|
◎ Target | Chris Woronka ★★★★☆ #869 | Hold | $34.00→ $29.00-14.7% |
|
Sep 15
18:19 UTC
|
BBNX
Beta Bionics
|
◎ Target | Travis Steed ★★★★☆ #673 | Neutral | $18.00→ $20.00+11.1% |
|
Sep 15
17:19 UTC
|
RFIL
RF Industries
|
◎ Target | Tyler Burmeister ★★☆☆☆ #2895 | Buy | $19.00→ $17.00-10.5% |
|
Sep 15
17:19 UTC
|
RFIL
RF Industries
|
◎ Target | Josh Nichols ★★★☆☆ #1708 | Buy | $15.00→ $12.00-20.0% |
|
Sep 15
17:19 UTC
|
RBLX
Roblox
|
◎ Target | Eric Handler ★★★☆☆ #1229 | Buy | $55.00→ $60.00+9.1% |
|
Sep 15
17:19 UTC
|
PAYS
Paysign
|
◎ Target | Jacob Stephan ★★☆☆☆ #2532 | Buy | $13.00→ $15.00+15.4% |
|
Sep 15
17:19 UTC
|
FTI
TechnipFMC
|
◎ Target | Scott Gruber ★★★☆☆ #1156 | Buy | $80.00→ $85.00+6.2% |
|
Sep 15
17:19 UTC
|
CHYM
Chime Financial
|
◎ Target | Will Nance ★★★★☆ #886 | Buy | $33.00→ $37.00+12.1% |
|
Sep 15
17:19 UTC
|
ABOS
Acumen Pharmaceuticals
|
◎ Target | Geoff Meacham ★★★☆☆ #1350 | Buy | $4.00→ $5.00+25.0% |
|
Sep 15
16:19 UTC
|
VNO
Vornado Realty Trust
|
◎ Target | Anthony Paolone ★★★☆☆ #1306 | Neutral | $37.00→ $39.00+5.4% |
|
Sep 15
16:19 UTC
|
VICI
VICI Properties
|
◎ Target | Ronald Kamdem ★★★☆☆ #1858 | Equal Weight | $31.00→ $29.00-6.5% |
|
Sep 15
16:19 UTC
|
VC
Visteon
|
◎ Target | Rajat Gupta not yet tracked | Overweight | $170.00→ $145.00-14.7% |
|
Sep 15
16:19 UTC
|
SRRK
Scholar Rock
|
◎ Target | Allison Bratzel ★★☆☆☆ #2582 | Overweight | $60.00→ $75.00+25.0% |
|
Sep 15
16:19 UTC
|
SNX
TD SYNNEX
|
◎ Target | Erik Woodring ★★★☆☆ #1328 | Overweight | $374.00→ $334.00-10.7% |
|
Sep 15
16:19 UTC
|
OBIO
Orchestra BioMed
|
◎ Target | Madison El-Saadi not yet tracked | Buy | $10.00→ $11.00+10.0% |
|
Sep 15
16:19 UTC
|
GTX
Garrett Motion
|
◎ Target | Rajat Gupta not yet tracked | Overweight | $37.00→ $35.00-5.4% |
|
Sep 15
16:19 UTC
|
FTK
Flotek Industries
|
◎ Target | Robert Brown ★☆☆☆☆ #3100 | Buy | $40.00→ $44.00+10.0% |
|
Sep 15
16:19 UTC
|
CTNM
Contineum Therapeutics
|
◎ Target | Debanjana Chatterjee ★★☆☆☆ #2821 | Buy | $26.00→ $24.00-7.7% |
|
Sep 15
16:19 UTC
|
AU
AngloGold Ashanti
|
◎ Target | Patrick Jones ★★☆☆☆ #2267 | Overweight | $134.00→ $140.00+4.5% |
|
Sep 15
15:19 UTC
|
MCD
McDonald's
|
◎ Target | Logan Reich ★★★☆☆ #1166 | Sec→ r Perform | $295.00→ $290.00-1.7% |
|
Sep 15
15:19 UTC
|
CMS
CMS Energy
|
◎ Target | Julien Dumoulin-Smith not yet tracked | Hold | $78.00→ $74.00-5.1% |
|
Sep 15
15:19 UTC
|
AXR
AMREP
|
◎ Target | Zhiger Kurmet not yet tracked | Hold | $26.00→ $22.00-15.4% |
|
Sep 15
14:19 UTC
|
SION
Sionna Therapeutics
|
◎ Target | Laura Chico ★★☆☆☆ #2636 | Neutral | $5.00→ $6.00+20.0% |
|
Sep 15
14:19 UTC
|
PLTR
Palantir Technologies
|
◎ Target | Karl Keirstead ★★★★☆ #375 | Buy | $220.00→ $250.00+13.6% |
|
Sep 15
14:19 UTC
|
PLAY
Dave & Buster's Entertainment
|
◎ Target | Dennis Geiger ★★★☆☆ #2244 | Neutral | $12.00→ $9.00-25.0% |
|
Sep 15
14:19 UTC
|
PLAY
Dave & Buster's Entertainment
|
◎ Target | Andrew Strelzik ★★☆☆☆ #2820 | Outperform | $22.00→ $13.00-40.9% |
|
Sep 15
14:19 UTC
|
LIF
Life360
|
◎ Target | Wyatt Swanson ★★★☆☆ #1054 | Neutral | $47.00→ $40.00-14.9% |
|
Sep 15
14:19 UTC
|
IVA
Inventiva
|
◎ Target | Seamus Fernandez ★★★☆☆ #2033 | Buy | $11.00→ $14.00+27.3% |
|
Sep 15
14:19 UTC
|
IRT
Independence Realty Trust
|
◎ Target | Ami Probandt ★★★☆☆ #1624 | Buy | $19.00→ $18.00-5.3% |
|
Sep 15
14:19 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Brad Canino not yet tracked | Buy | $89.00→ $80.00-10.1% |
|
Sep 15
14:19 UTC
|
IMMX
Immix Biopharma
|
◎ Target | Graig Suvannavejh ★★☆☆☆ #2716 | Outperform | $15.00→ $26.00+73.3% |
|
Sep 15
14:19 UTC
|
GLW
Corning
|
◎ Target | John Roberts not yet tracked | Outperform | $210.00→ $180.00-14.3% |
|
Sep 15
14:19 UTC
|
ENVA
Enova International
|
◎ Target | Moshe Orenbuch ★★★★☆ #733 | Buy | $257.00→ $220.00-14.4% |
|
Sep 15
14:19 UTC
|
DRI
Darden Restaurants
|
◎ Target | Brian Bittner ★★★★☆ #770 | Outperform | $235.00→ $245.00+4.3% |
|
Sep 15
14:19 UTC
|
CSR
Centerspace
|
◎ Target | firm only | Neutral | $70.00→ $68.00-2.9% |
|
Sep 15
14:19 UTC
|
BNTC
Benitec Biopharma
|
◎ Target | Yun Zhong ★★☆☆☆ #2523 | Outperform | $16.00→ $17.00+6.2% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.